- Home
- Automated
- List of product information
- FEXODIN FILM COATED TABLET 180MG [SIN14591P]
FEXODIN FILM COATED TABLET 180MG [SIN14591P]
Active ingredients: FEXODIN FILM COATED TABLET 180MG
Last updated 26 October 2025
Product Info
FEXODIN FILM COATED TABLET 180MG
[SIN14591P]
Product information
Active Ingredient and Strength | FEXOFENADINE HYDROCHLORIDE - 180 MG |
Dosage Form | TABLET, FILM COATED |
Manufacturer and Country | MEDREICH LIMITED - INDIA |
Registration Number | SIN14591P |
Licence Holder | PHARMAZEN MEDICALS PTE LTD |
Forensic Classification | PRESCRIPTION ONLY MEDICINES |
Anatomical Therapeutic Chemical (ATC) code | R06AX26 |
Therapeutic indications
Fexodin-120mg is indicated for the relief of symptoms associated with Allergic Rhinitis (AR) in adults and children 12 years of age and older.
Fexodin-180mg is indicated for the relief of symptoms associated with Seasonal Allergic Rhinitis (SAR) and Chronic Idiopathic Urticaria (CIU) in adults and children 12 years of age and older.
Posology and method of administration:
The recommended dose of fexofenadine hydrochloride for adults and children aged 12 years and over is 120 mg once daily.
The recommended dose of fexofenadine hydrochloride for adults and children aged 12 years and over is 180 mg once daily.
Children under 12 years of age
Fexodin is not indicated for children younger than 12 years of age.
Special risk groups
The safety and efficacy of fexofenadine hydrochloride in renally or hepatically impaired children have not been established. Studies conducted in adults in special risk groups (renally or hepatically impaired patients) indicate that it is not necessary to adjust the dose of fexofenadine hydrochloride in adults.
Contraindications
Hypersensitivity to the active substance or to any of the excipients.